Content about Multiple myeloma

April 4, 2013

Dr. Reddy's launches generic osteoporosis drug

Dr. Reddy's Labs has launched zoledronic acid injection in the 5 mg-per-100-mL strength, the Indian generic drug maker Thursday.

February 8, 2013

FDA approves multiple myeloma drug

The Food and Drug Administration has approved a new drug made by Celgene for treating the cancer multiple myeloma, the agency said Friday.

July 23, 2012

FDA approves blood cancer drug

The Food and Drug Administration has approved a new drug for treating multiple myeloma, the agency said Friday.

June 1, 2011

XTL granted orphan drug designation for multiple myeloma treatment

The Food and Drug Administration has given orphan drug designation to an investigational treatment for multiple myeloma, a blood cell cancer, that soon will enter mid-stage development.

December 9, 2010

Study shows 50% reduction of myeloma among patients

A new three-drug combination may work as a front-line treatment for cancer of the plasma cells, according to an early-stage clinical study.

December 7, 2010

Watson, Natco ink deal for generic Revlimid

U.S. generic drug maker Watson Pharmaceuticals and Indian drug maker Natco Pharma will work together to develop and commercialize a generic drug used for bone marrow disorders, the two companies said Tuesday.

March 21, 2010

Decision Resources projects more than 150% growth in multiple myeloma market

The market for drugs that treat a cancer of the bone marrow will more than...